Biomolecules,
Год журнала:
2024,
Номер
14(5), С. 514 - 514
Опубликована: Апрель 24, 2024
Musculoskeletal
diseases
(MSDs),
including
osteoarthritis
(OA),
osteosarcoma
(OS),
multiple
myeloma
(MM),
intervertebral
disc
degeneration
(IDD),
osteoporosis
(OP),
and
rheumatoid
arthritis
(RA),
present
noteworthy
obstacles
associated
with
pain,
disability,
impaired
quality
of
life
on
a
global
scale.
In
recent
years,
it
has
become
increasingly
apparent
that
N6-methyladenosine
(m6A)
is
key
regulator
in
the
expression
genes
multitude
biological
processes.
m6A
composed
0.1–0.4%
adenylate
residues,
especially
at
beginning
3′-UTR
near
translation
stop
codon.
The
can
be
classified
into
three
types,
namely
“writer”,
“reader”,
“eraser”.
Studies
have
shown
epigenetic
modulation
influences
mRNA
processing,
nuclear
export,
translation,
splicing.
Regulated
cell
death
(RCD)
autonomous
orderly
cells
under
genetic
control
to
maintain
stability
internal
environment.
Moreover,
distorted
RCDs
are
widely
used
influence
course
various
receiving
increasing
attention
from
researchers.
past
few
evidence
indicated
regulate
gene
thus
different
RCD
processes,
which
central
role
etiology
evolution
MSDs.
currently
confirmed
autophagy-dependent
death,
apoptosis,
necroptosis,
pyroptosis,
ferroptosis,
immunogenic
NETotic
oxeiptosis.
m6A–RCD
axis
inflammatory
response
chondrocytes
invasive
migratory
MM
bone
remodeling
capacity,
thereby
influencing
development
This
review
gives
complete
overview
regulatory
functions
across
muscle,
bone,
cartilage.
addition,
we
also
discuss
advances
by
m6A-targeted
factors
explore
clinical
application
prospects
therapies
targeting
MSD
prevention
treatment.
These
may
provide
new
ideas
directions
for
understanding
pathophysiological
mechanism
MSDs
treatment
these
diseases.
Clinical & Experimental Immunology,
Год журнала:
2024,
Номер
217(1), С. 57 - 77
Опубликована: Март 20, 2024
Abstract
The
enzymatic
core
component
of
m6A
writer
complex,
Mettl3,
plays
a
crucial
role
in
facilitating
the
development
and
progress
gastric
colorectal
cancer
(CRC).
However,
its
underlying
mechanism
regulating
intestinal
inflammation
remains
unclear
poorly
investigated.
First,
characteristics
Mettl3
expression
inflammatory
bowel
diseases
(IBD)
patients
were
examined.
Afterward,
we
generated
mice
line
with
epithelial
cells
(IECs)-specific
deletion
verified
by
various
experiments.
We
continuously
recorded
compared
physiological
status
including
survival
rate
etc.
between
two
groups.
Subsequently,
took
advantage
staining
assays
to
analyze
mucosal
damage
immune
infiltration
Mettl3WT
Mettl3KO
primary
IECs.
Bulk
RNA
sequencing
was
used
pursuit
differential
genes
(DEGs)
associated
signaling
pathways
after
losing
Mettl3.
Pyroptosis-related
proteins
determine
whether
cell
death
caused
pyroptosis.
Eventually,
CyTOF
performed
probe
difference
CD45+
cells,
especially
CD3e+
T-cell
clusters
In
IBD
patients,
highly
expressed
inner-nucleus
IECs
while
significantly
decreased
upon
acute
inflammation.
IECs-specific
KO
triggered
wasting
phenotype
developed
spontaneous
colitis.
rate,
body
weight,
length
observed
from
2
8
weeks
lower
than
mice.
degree
even
more
serious
their
WT
littermate.
demonstrated
that
DEGs
dramatically
enriched
NOD-signaling
due
loss
colonic
epithelium
prone
pyroptosis
revealed
T
have
altered
Mettl3KO.
Furthermore,
there
abnormal
proliferation
CD4+
markedly
exhaustion
CD8
+
severe
is
located
declined
when
occurs.
prevented
developing
Journal of Neurogenetics,
Год журнала:
2023,
Номер
37(3), С. 103 - 114
Опубликована: Июль 3, 2023
AbstractIschemic
stroke
(IS)
can
cause
neuronal
cell
loss
and
function
defects.
Exosomes
derived
from
neural
stem
cells
(NSC-Exos)
improve
plasticity
promote
repair
following
IS.
However,
the
potential
mechanism
remains
unclear.
In
this
study,
NSC-Exos
were
characterized
co-cultured
with
microglia.
We
found
that
increased
NRF2
expression
in
oxygen–glucose
deprivation/reoxygenation
LPS-induced
microglia
converted
M1
pro-inflammatory
phenotype
to
M2
anti-inflammatory
phenotype.
reduced
m6A
methylation
modification
of
nuclear
factor
erythroid
2-related
2
(NRF2)
mRNA
via
obesity-associated
gene
(FTO).
Furthermore,
damage
neurons
caused
by
microglia's
inflammatory
response.
Finally,
changes
polarization
neuron
FTO
knockdown
NSE-Exos
attenuated
overexpression
These
findings
revealed
promotes
microglial
transferring
FTO,
thereby
resulting
neuroprotective
effects.Keywords:
NSC-Exosm6AFTONRF2
Author
contributionsConception
manuscript:
Zhiyong
Li,
Zhenggang
Chen,
Jun
Peng.
Manuscript
design
writing:
Li.
reviewing
editing:
All
authors
read
agreed
final
version
manuscript.Disclosure
statementNo
conflict
interest
was
reported
author(s).Data
availability
statementData
sharing
not
applicable
article
as
no
datasets
generated
or
analysed
during
current
study.Additional
informationFundingThis
work
supported
High-level
Talents
Project
Hainan
Natural
Science
Foundation
[822RC865]
Cerebrovascular
Disease
Clinical
Medical
Research
Center
[LCYX202309].
Abstract
Background
Aberrant
proliferation
of
vascular
smooth
muscle
cells
(VSMCs)
is
the
cause
neointima
formation
followed
by
injury.
Autophagy
involved
in
this
pathological
process,
but
its
function
controversial.
Recently,
we
found
that
methyltransferase
like
3
(METTL3)
inhibited
VSMC
activating
autophagosome
formation.
Moreover,
also
demonstrated
METTL3
reduced
levels
phosphorylated
mammalian
target
rapamycin
(p-mTOR)
and
cyclin
dependent
kinase
1
(p-CDK1/CDC2),
which
were
critical
for
autophagy
regulation.
However,
whether
mTOR
CDK1
mediated
on
VSMCs
remains
unknown.
Results
We
showed
activator
mTOR,
MHY1485
largely
reversed
effects
overexpression
proliferation.
Rapamycin,
inhibitor
obviously
nullified
pro-proliferation
knockdown
VSMCs.
Unexpectedly,
did
not
contribute
to
impacts
migration
phenotypic
switching
On
other
hand,
with
deficiency,
was
METTL3-regulated
VSMCs,
effect
autophagy.
Conclusions
concluded
role
Biomolecules,
Год журнала:
2024,
Номер
14(5), С. 514 - 514
Опубликована: Апрель 24, 2024
Musculoskeletal
diseases
(MSDs),
including
osteoarthritis
(OA),
osteosarcoma
(OS),
multiple
myeloma
(MM),
intervertebral
disc
degeneration
(IDD),
osteoporosis
(OP),
and
rheumatoid
arthritis
(RA),
present
noteworthy
obstacles
associated
with
pain,
disability,
impaired
quality
of
life
on
a
global
scale.
In
recent
years,
it
has
become
increasingly
apparent
that
N6-methyladenosine
(m6A)
is
key
regulator
in
the
expression
genes
multitude
biological
processes.
m6A
composed
0.1–0.4%
adenylate
residues,
especially
at
beginning
3′-UTR
near
translation
stop
codon.
The
can
be
classified
into
three
types,
namely
“writer”,
“reader”,
“eraser”.
Studies
have
shown
epigenetic
modulation
influences
mRNA
processing,
nuclear
export,
translation,
splicing.
Regulated
cell
death
(RCD)
autonomous
orderly
cells
under
genetic
control
to
maintain
stability
internal
environment.
Moreover,
distorted
RCDs
are
widely
used
influence
course
various
receiving
increasing
attention
from
researchers.
past
few
evidence
indicated
regulate
gene
thus
different
RCD
processes,
which
central
role
etiology
evolution
MSDs.
currently
confirmed
autophagy-dependent
death,
apoptosis,
necroptosis,
pyroptosis,
ferroptosis,
immunogenic
NETotic
oxeiptosis.
m6A–RCD
axis
inflammatory
response
chondrocytes
invasive
migratory
MM
bone
remodeling
capacity,
thereby
influencing
development
This
review
gives
complete
overview
regulatory
functions
across
muscle,
bone,
cartilage.
addition,
we
also
discuss
advances
by
m6A-targeted
factors
explore
clinical
application
prospects
therapies
targeting
MSD
prevention
treatment.
These
may
provide
new
ideas
directions
for
understanding
pathophysiological
mechanism
MSDs
treatment
these
diseases.